ABSTRACT -We monitored transcriptional changes in yeast cells in response to induced expression of the core protein of hepatitis C virus (HCV) using a DNA microarray. Expression of 16 genes involved in the unfolded-protein response was enhanced by inducing expression of the core protein in yeast cells.
INTRODUCTION
Chronic infection with hepatitis C virus (HCV) causes liver cirrhosis and hepatocellular carcinoma (Saito et al., 1990) . HCV has a positive-stranded RNA genome that encodes a polyprotein of 3,010 amino acids, which is cleaved to yield the structural core protein, E1 and E2 polypeptides, and seven nonstructural polypeptides (Bartenschlager et al., 2004) .
The HCV core protein has RNA-binding activity and is the major component of the viral nucleocapsid (McLauchlan, 2000; Ray and Ray, 2001 ). In addition, it induces lipid accumulation in hepatocytes, perhaps being responsible for HCV-associated steatosis (Negro, 2006) . The protein has also been implicated in modulation of cellular processes that include apoptosis, transformation, and host-cell gene expression (McLauchlan, 2000) . We reported previously (Isoyama et al., 2002) that HCV core protein repressed nuclear translocation of a cellular protein in the budding yeast Saccharomyces cerevisiae. Our results suggested that processing and localization of HCV core protein in yeast cells might reflect similar phenomena in mammalian cells. In the present study, we examined gene expression of yeast cells in response to HCV core protein by DNA microarray analysis.
MATERIALS AND METHODS

Yeast strains, media and construction of an expression vector for HCV core protein
Yeast cells were grown in a synthetic rafinose medium [1.67% Bacto TM yeast nitrogen base w/o amino acids (Difco, Detroit, MI, USA) and 2% rafinose] supplemented with 0.04 mg/ml adenine and amino acids (SR dropout; Ausubel et al., 1997) at 30°C. For activation of the GAL1 promoter, galactose was added to 3%. To construct an expression vector for HCV core protein, we isolated the entire core encoding region (core; amino acid residues 1-191) of HCV (1b) (hepatitis C virus isolate HCR6; Genbank accession no. AY045702) by PCR (Isoyama et al., 2002) and introduced it between the GAL1 promoter and the GAPDH terminator of pRS425-GAL, a pRS425-based (multicopy) vector. Saccharomyces cerevisiae strain BY4742 (MATα his3Δ1 leu2Δ lys2Δ ura3Δ) was transformed with the resultant expression vector and also with the empty vector, as a control.
Isolation of RNA
Yeast cells carrying pRS425-GAL-core and yeast cells carrying pRS425 were diluted in SR dropout (-leu) medium at A 600 =0.045 and cultured for 8 hr. Then they were cultured for a further 2 hr after the addition Correspondence: Shusuke KUGE (E-mail: skuge@mail.pharm.tohoku.ac.jp) Genes whose level of expression is more than doubled by the UPR induced by tunicamycin treatment (Travers et al., 2000) , b) Gene whose expression is repressed by the UPR induced by tunicamycin treatment (Travers et al., 2000) , c) Functions (GO_process) are taken from the Saccharomyces genome database (www.yeastgenome.org), d) Average of changes (-fold); n=3, e) S.D. standard deviation. of galactose at a final concentration of 3%. We prepared total RNA from yeast cells using Ribo-Pure TMYeast (Ambion, Austin, TX).
Microarray analysis
Total RNA (5 μg) from each of three independent cultures per experimental or control group was applied to a GeneChip ® Yeast genome 2.0 array in accordance with the manufacturer's instructions (Affymetrix, Santa Clara, CA). We used a One-Cycle cDNA synthesis kit to synthesize the double stranded cDNA from the total RNA, and a GeneChip ® IVT Labeling kit to synthesize the cRNA from the double-stranded cDNA as a template. A mixture of total RNA and the polyA RNA control was reverse-transcribed with an T7-Oligo (dT) primer. After second-strand synthesis, we purified the double-stranded cDNA and used it as a template for biotin-labeled cRNA synthesis. The GeneChip ® was hybridized with 5 μg of cRNA and washed with the Fluidics station 450 (Affymetrix). A fluorescent image of the G eneChip ® was then recorded with the GeneChip ® Scanner 3000 (Affymetrix). Data tables created by GeneChip Operating Software 1.2 were imported into GeneSpring 7 (Agilent Technologies Inc., Palo Alto, CA) for normalization of the results on each chip and for further analysis. We selected genes (1,853 genes) each of which a ratio of the standard deviation to the expression level average (n=3) was less than 10%.
RESULTS AND DISCUSSION
Genes whose levels of expression were more than doubled or more than halved, when expression of HCV core was induced for 2 hr are listed in Table 1 . Among 44 genes whose expression was enhanced by expression of HCV core, 16 genes were identical to those induced during the unfolded-protein response (UPR; Travers et al., 2000 ; tunicamycin treatment for 60 min). Many of the proteins encoded by 44 genes were involved in the UPR and ER-associated degradation. Expression of seven genes that are repressed during the UPR (Travers et al., 2000) was also suppressed by HCV core (Table 1) . Our results suggest that HCV core expression resulted in the UPR in yeast cells. The response of yeast cells to HCV core probably reflects the effects of HCV core on human hepatoma cells (Benali-Furet et al., 2005) .
